Source: Annual Congress 2010 - Staging of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. P. Vaz, G. Fernandes, C. Souto Moura, P. Bastos, H. Queiroga, V. Hespanhol (Oporto, Portugal). Clinical and pathologic staging – PET/CT impact. Eur Respir J 2010; 36: Suppl. 54, 5442

Member's Comments

No comment yet.

Related content which might interest you: PET/CT in the preoperative staging of lung cancer – Case series Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010 Is mediastinoscopy necessary in patients with negative EBUS-TBNA – A challenge to the ESTS Guidelines for staging of lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis – Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 TTF-1 in advanced SCLC – Diagnostic and prognostic relevance Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Diagnostic value of PET-CT in pleural diseases Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Value of the video assisted mediastinoscopy in the thoracic pathology – Our experience Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Pseudotumoral lung tuberculuosis – A controversed clinical and imagistic entity Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Correlation of 18F-FDG PET/CT with inflammatory biomarkers in sarcoidosis Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Transcutaneous Contrast-Enhanced Ultrasonography (CEUS) of peripheral lung lesions – Our experience in Clinical County Hospital of Constanta Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010 Predictive value of pre-test clinical diagnosis for mediastinal lymphadenopathy compared to histological outcomes from cervical mediastinoscopy Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Preoperative predictive value of 18FDG CT/PET tumor metabolic parameters & SUV lymh nodes/tumor ratio in NSCLC Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery Year: 2015 Lymphangioleiomyomatosis – Clinical characteristics and longitudinal follow-up of 36 cases Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Chronic lung disease of prematurity: 10 years follow-up using clinical parameters and MR imaging – initial results Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Multifocal cavitary lung adenocarcinoma: Clinical, radiologic and pathologic features Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Interstitial lung diseases in children – Clinical and pathological characteristics Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 The first 100 EBUS-TBNA examinations at an university hospital – indications and diagnostic yield Source: Annual Congress 2009 - Biopsy techniques Year: 2009 Mediastinal masses: Clinical, radiological and pathological analysis Source: International Congress 2018 – Pleural effusions, infections and tumours Year: 2018 Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020 Surgery for treatment and diagnosis of primary anterior mediastinal tumours – ten years review Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009